Bausch Health Companies (BHC.TO, BHC) on Tuesday priced its previously announced offering of US$4.4 billion aggregate principal amount of 10% senior secured notes due 2032 through an indirect wholly owned subsidiary.
The company said the offering was upsized from an initial offering size of $4 billion aggregate principal amount and is expected to close the offering on April 8.
Bausch Health intends to use the proceeds from the offering and borrowings under the New Term Loan Facility to: repay in full and cancel its existing credit agreement; and redeem all of its 5.500% Senior Secured Notes due 2025, 9.000% Senior Notes due 2025, 6.125% Senior Secured Notes due 2027, 5.750% Senior Secured Notes due 2027 and its indirect unit's 9.000% Senior Secured Notes due 2028; and pay related fees, premiums and expenses; and for general corporate purposes.
Shares of the company were last seen udown 0.85% at $10.33 on the Toronto Stock Exchange.
免責聲明：投資有風險，本文並非投資建議，以上內容不應被視為任何金融產品的購買或出售要約、建議或邀請，作者或其他用戶的任何相關討論、評論或帖子也不應被視為此類內容。本文僅供一般參考，不考慮您的個人投資目標、財務狀況或需求。TTM對信息的準確性和完整性不承擔任何責任或保證，投資者應自行研究並在投資前尋求專業建議。